LUCIUS 卢修斯 福巴替尼 Futibatinib肝内胆管癌

福巴替尼

美国FDA批准上市产品,疗效确切
卢修斯制药(老挝)有限公司出品

Futibatinib

老挝国家食药监局批准上市
老挝国家药检所检测认证

Composition:
Each film-coated tabler contains Futbatinib .. Amg.

LUCIUS

肝内胆管癌

LuciFutib is a kinase inhibitor indicated for tnc

PHARMACEUTICALS

treatment of adult patients with previously treated
wnresectable. locally advanced or melastatle
Intrahenatic cholangiocarcinoma laroonig
rmetactatie
fibroblast growth ractor receptor 2 (FOFR2) gene
fnsions or other rearrangements

LuciFutib

* Contirm the presence of an FOFR2 eene fusion
or other rearrangement prior to initiation of
treatment with LuciFutib.
* Recommended dose is 20 me orallv (five 4 mg
tabletsi once daily until disease progression o

Futibatinib Tablets

unacceptable toxicity occurs.

4mg

FDA批准

Saallow tablet whole, wiin or WIOu Too
Sorages in a dry place and store at 20 Cto35C.
Warnines

Rx only

Keep medicine out of reach of Children. Do not
administer LuciFutio during Pregnancy and
PLEASE SEE PACKAGE INSERT
Manufactured and Marketed by:
LUCIUS

权威认证

Thonemane village. Xaythany district,
Vientiane Caital. Laos
Warning : lo be soid Dy retaul on prescrption
eslcred pirysacians only, and as directo

35 Tablets

口碑质量

适应症:
福巴替尼是一种激酶抑制剂,用于治疗患有成纤维细胞生
长因子受体2(FGFR2)基因融合或其他重排的、既往接
受过治疗的、不可切除的、局部晚期或转移性肝内胆管癌

的成年患者。
推荐剂量:
1、每日口服一次,每次20mg,直至病情进展或出现不可
接受的毒性。
2、可与食物同服或单独服用。